Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions

Detalles Bibliográficos
Formato:	Electrónico Libro electrónico
Lenguaje:	Inglés
Publicado:	Marketline 2007
Materias:	Pharmaceutical Industry
Acceso en línea:	Available in Business Source Complete.
Aporte de:	Registro referencial: Solicitar el recurso aquí Bibliotecas (UCSF) de Universidad Católica de Santa Fe


LEADER	00888nam a22002412 4500
001	ebs53686670e
003	EBZ
006	m d \|\|\|\|\|\|
007	cr\|unu\|\|\|\|\|\|\|\|
008	200707nuuuuuuuuxx \|\|\|\| s\|\|\|\|\|\|\|\|\|\|\|eng\|d
035			\|a (EBZ)ebs53686670e
040			\|a EBZ
042			\|a msc
050	0	0	\|a RS
130	0		\|a Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions (Online)
245	0	0	\|a Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions \|h [electronic resource].
260			\|b Marketline \|c 2007
650	0	7	\|a Pharmaceutical Industry \|2 EBSCO-TLI
773	0		\|t Business Source Complete \|d EBSCO
856	4	0	\|3 Full text available: Jun 2007. \|z Available in Business Source Complete. \|u https://search.ebscohost.com/direct.asp?db=bth&jid=%225DBF%22&scope=site
999			\|c 95484 \|d 95484
942			\|z EBS
942			\|c REL

Ejemplares similares